Received Apr 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z002903 | — |
no symptomatic adverse events were reported; the vaccines were late right away; one dose of GARDASIL-9 was administered to a patient; This spontaneous report was received from a nurse and refers to a(n) 13-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-Apr-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL-9) injection, lot #Z002903, expiration date: 15-Dec-2026, 0.5 ml / once, product quantity: 1, administered for prophylaxis (strength and route, anatomical site were not provided). The Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL-9) that had arrived after the "must receive by date" (Product shipment delay). The vaccine was received on 07-Apr-2025 and had a must receive by date of 06-Apr-2025. It was reported that they did not catch that the vaccines were late right away and the vaccines appeared to still be cool (Improper storage of product in use). It was confirmed no symptomatic adverse events were reported in the patient who received the dose (No adverse event). Reporter was returning 19 of the 20 doses she ordered.; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02784533-02784524 , CLIC number : , ESTAR number : , IRMS number : 500UW00000Y0zmKYAR|08042025150020|7379 , Central date : 2025-04-08 , Classification : DMC, Attachment description : NSC Call , Safety case number : , MNSC case number : 02784533 , MNSC interaction number : 02784524 , Integration log UniqueID : 500UW00000Y0zmKYAR|08042025150020|7379 , Service cloud CaseID : 500UW00000Y0zmKYAR